Sage Journals: Discover world-class research

Abstract

HIV-infected ethnic minorities are underrepresented in HIV research. We sought to better understand the reasons for the low participation rates. An anonymous 1-page survey was administered to HIV-infected patients attending primary care clinics at the CORE Center in Chicago during 8 weeks in 2007. Four hundred seventeen HIV-infected patients (mean age, 43 years; 60% male, 65% African American, 21% Hispanic) completed the survey. Forty percent had previously participated in research but only 29% had ever been asked by their primary care provider (PCP) to participate. The strongest predictor of participation was being asked (RR 3.0; p < 0.001). The majority of patients would agree (65%) or consider (30%) participating in a study if recommended by their PCP. Being treated like a “guinea pig” was the most common (40%) concern of patients. However, despite this concern, patients would still agree to participate if recommended by their PCP. In our urban cohort of HIV-infected patients, the majority were willing to participate in HIV research studies if asked, highlighting the important role of primary providers in improving research participation.

Get full access to this article

View all access options for this article.

References

Gifford

, Cunningham

, Heslin

et al. Participation in research and access to experimental treatments by HIV infected patients. N Engl J Med, 2003; 346:1373–1382.

Mills

, Wilson

, Rachlis

et al. Barriers to participation in HIV drug trials. Lancet Infect Dis, 2006; 6:32–38

Stone

, Mauch

, Steger

et al. Race, gender, drug use and participation in AIDS clinical trials. J Gen Intern Med, 1997; 12:150–157.

Murthy

, Krumholz

, Gross

. Participation in cancer clinical trials: Race, sex and age-based disparities. JAMA, 2004; 291:2720–2726.

Gross

, Filardo

, Mayne

et al. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer, 2005; 103:483–491.

Gandhi

, Ameli

, Bacchetti

et al. Eligibility criteria for HIV clinical trials and generalizability of results: The gap between published reports and study protocols. AIDS, 2005; 19:1885–1896.

Slomka

, Ratliff

, McCurdy

et al. Decisions to participate in research: Views of underserved minority drug users with or at risk for HIV. AIDS Care, 2008; 10:1224–1232.

Garber

, Hanusa

, Switzer

et al. HIV-infected African-Americans are willing to participate in HIV treatment trials. J Gen Intern Med, 2007; 22:17–42.

Ding

, Powe

, Manson

et al. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials. Arch Intern Med, 2007; 167:905–912.

10.

Shavers

, Lynch

, Burmeister

. Knowledge of the Tuskegee Study and its impact on the willingness to participate in medical research studies. J Natl Med Assoc, 2000; 92:563–572.

11.

Seto

. History of medical ethics and perspectives on disparities in minority recruitment and involvement in health research. Am J Med Sci, 2001; 322:248–252.

12.

Freimuth

, Quinn

, Thomas

, Cole

, Zook Eric

. African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med, 2001; 52:797–808.

13.

Corbie-Smith

, Thomas

, Williams

, Moody-Ayers

. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med, 1999; 14:537–546.

14.

Newman

, Naihua

, Roberts

et al. HIV Vaccine trial participation among ethnic minority communities: Barriers, motivators and implications for recruitment. J Acquire Immune Defic Syndrome, 2006; 41:210–217.

15.

Gwadz

, Leonard

, Nakagawa

et al. Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgrounds. AIDS Care, 2006; 18:786–794.

16.

Sengupta

, Strauss

, DeVellis

et al. Factors affecting African-American participation in AIDS research. J Acquir Immune Defic Syndr Hum Retrovirol, 2000; 24:275–284.

17.

Durant

, Davis

, St. George

et al. Participation in research studies: Factors associated with failing to meet minority recruitment goals. Ann Epidemiol, 2007; 17:634–642.

18.

King

, DeFreitas

, Smith

et al. A descriptive study of the attitudes and perceptions of ACTG site coordinators on HIV clinical trial recruitment and retention. AIDS Patient Care STDs, 2007; 21:551–563.

19.

Embi

, Jain

, Clark

. Effect of a clinical trial alert system on physician participation in trial recruitment. Arch Intern Med, 2005; 165:2272–2277.

20.

Embi

, Jain

, Harris

. Physicians perception of an electronic health record-based clinical trial alert approach to subject recruitment: A survey. BMC Med Inform Decis Mak, 2008; 8:13.

21.

Worthington

, Gill

. Participation in HIV research: The importance of clinic contact factors. AIDS Patient Care STDs, 2008; 22:619–625.

22.

Freedberg

, Sullivan

, Georgakis

et al. Improving participation in HIV clinical trials: Impact of a brief intervention. HIV Clin Trials, 2001; 2:205–212.

23.

Powell

, Fleming

, Walker-McGill

et al. The project IMPACT experience to date: Increasing minority participation and awareness of clinical trials. J Natl Med Assoc, 2008; 100:178–187.

24.

Sullivan

, McNaghten

, Begley

et al. Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicine. J Natl Med Assoc, 2007; 99:242–250.

HIV-Infected Adults from Minority Ethnic Groups Are Willing to Participate in Research If Asked

Abstract

Get full access to this article

References